Aswin Mangerich
Impact in
- Aging top 1%
- Genetics, Aging, and Longevity in Model Organisms
- Geriatrics and Gerontology top 1%
- Sirtuins and Resveratrol in Medicine
Papers in
- Oncology 31
- PARP inhibition in cancer therapy 30
-
- DNA Repair Mechanisms 24
- Co-authors
- Alexander Bürkle (36 shared papers)Peter C. Dedon (6 shared papers)Sebastian Veith (8 shared papers)Annika Marie Krüger (7 shared papers)Karin Hauser (4 shared papers)Arthur Fischbach (10 shared papers)James G. Fox (3 shared papers)Steven R. Tannenbaum (3 shared papers)
- Journals
- Archives of Toxicology (10 papers)Nucleic Acids Research (9 papers)Toxicology Letters (4 papers)Cells (3 papers)Nature Communications (3 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Aswin Mangerich
69 papers receiving 2.8k citations
Aswin Mangerich's Hit Papers
Peers
Comparison fields: 5 of 122
- Aging 150
- Geriatrics and Gerontology 295
- Oncology 694
- Molecular Biology 1.2k
- Physiology 63
Countries citing papers authored by Aswin Mangerich
This map shows the geographic impact of Aswin Mangerich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aswin Mangerich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aswin Mangerich more than expected).
Fields of papers citing papers by Aswin Mangerich
This network shows the impact of papers produced by Aswin Mangerich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aswin Mangerich. The network helps show where Aswin Mangerich may publish in the future.
Co-authors
The 25 scholars most cited alongside Aswin Mangerich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 310 | |
| 2 | ADP‐ribosyltransferases, an update on function and nomenclature Hit paper breakdown → | 2021 | 241 |
| 3 | 2019 | 240 | |
| 4 | 2012 | 218 | |
| 5 | 2013 | 99 | |
| 6 | 2012 | 97 | |
| 7 | 2017 | 91 | |
| 8 | 2018 | 84 | |
| 9 | 2021 | 83 | |
| 10 | 2010 | 76 | |
| 11 | 2020 | 74 | |
| 12 | 2014 | 60 | |
| 13 | 2020 | 56 | |
| 14 | 2010 | 55 | |
| 15 | 2021 | 54 | |
| 16 | 2013 | 51 | |
| 17 | 2020 | 51 | |
| 18 | 2013 | 46 | |
| 19 | 2014 | 46 | |
| 20 | 2020 | 46 |
About Aswin Mangerich
Aswin Mangerich is a scholar working on Oncology, Molecular Biology, Health, Toxicology and Mutagenesis, Geriatrics and Gerontology and Cancer Research, having authored 70 papers that have together received 2.9k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (30 papers), DNA Repair Mechanisms (24 papers), Carcinogens and Genotoxicity Assessment (7 papers), Pesticide Exposure and Toxicity (5 papers), Sirtuins and Resveratrol in Medicine (5 papers), Genetics, Aging, and Longevity in Model Organisms (4 papers), Heavy Metal Exposure and Toxicity (3 papers) and Spectroscopy Techniques in Biomedical and Chemical Research (3 papers). The work is most often cited by research in Aging (150 citations), Geriatrics and Gerontology (295 citations), Oncology (694 citations), Molecular Biology (1.2k citations) and Physiology (63 citations). Aswin Mangerich has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Alexander Bürkle, Peter C. Dedon, Sebastian Veith, Annika Marie Krüger, Karin Hauser, Arthur Fischbach, James G. Fox, Steven R. Tannenbaum, Gerald N. Wogan and Sascha Beneke. Their work appears in journals such as Archives of Toxicology, Nucleic Acids Research, Toxicology Letters, Cells and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.